Apoptosis in amyotrophic lateral sclerosis—what is the evidence?
- 1 August 2005
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 4 (8) , 500-509
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- RNAi knockdown of Par‐4 inhibits neurosynaptic degeneration in ALS‐linked miceJournal of Neurochemistry, 2004
- Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALSBiochemical and Biophysical Research Communications, 2004
- Protein aggregation in motor neurone disordersNeuropathology and Applied Neurobiology, 2003
- Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosisNeurological Sciences, 2003
- Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stressAmyotrophic Lateral Sclerosis, 2002
- Human caspase 12 has acquired deleterious mutationsBiochemical and Biophysical Research Communications, 2002
- Experimental Models of Amyotrophic Lateral SclerosisNeurobiology of Disease, 1999
- Anti-LFA-1α reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted ratsThe Journal of Heart and Lung Transplantation, 1999
- Caspases: killer proteasesTrends in Biochemical Sciences, 1997
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993